Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/bioinformatics-assisted-anti-hiv-therapy-GqmjNElu2K
References (49)
-
B Larder (1999)
Predicting HIV-1 phenotypic resistance from genotype using a large phenotype–genotype relational databaseAntivir. Ther., 4
-
A Cozzi-Lepri (2005)
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapyAntivir. Ther., 10
-
A Rendon (2005)
Clinical benefit of interventions driven by therapeutic drug monitoringHIV Med., 6
-
T Hastie, R Tibshirani, J Friedman (2001)
The Elements of Statistical Learning -
K Wang, E Jenwitheesuk, R Samudrala, JE Mittler (2004)
Simple linear model provides highly accurate genotypic predictions of HIV-1 drug resistanceAntivir. Ther., 9
-
ZW Cao (2005)
Computer prediction of drug resistance mutations in proteinsDrug Discov. Today, 10
-
I Savenkov (2005)
HAART outcome prediction using statistical learning methodsAntivir. Ther., 10
-
M Prosperi (2005)
'Common law' applied to treatment decisions for drug resistant HIVAntivir. Ther., 10
-
E Jenwitheesuk, K Wang, JE Mittler, R Samudrala (2005)
PIRSpred: a web server for reliable HIV-1 protein-inhibitor resistance/susceptibility predictionTrends Microbiol., 13
-
AG Marcelin (2003)
Genotypic inhibitory quotient as predictor of virological response to ritonavir–amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAntimicrob. Agents Chemother., 47
-
N Beerenwinkel (2005)
Estimating HIV evolutionary pathways and the genetic barrier to drug resistanceJ. Infect. Dis., 191
-
V DeGruttola (2000)
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis planAntivir. Ther., 5
-
MR Segal, JD Barbour, RM Grant (2004)
Relating HIV-1 sequence variation to replication capacity via trees and forestsStat. Appl. Genet. Mol. Biol., 3
-
AD Sevin (2000)
Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333J. Infect. Dis., 182
-
N Beerenwinkel (2002)
Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotypeProc. Natl Acad. Sci. USA, 99
-
LM Wahl, MA Nowak (2000)
Adherence and drug resistance: predictions for therapy outcomeProc. Biol. Sci., 267
-
T Sing, M Däumer (2005)
Antiretroviral Resistance in Clinical Practice -
AS Foulkes, V De Gruttola (2002)
Characterizing the relationship between HIV-1 genotype and phenotype: prediction-based classificationBiometrics, 58
-
L Bacheler (2004)
Estimation of phenotypic clinical cutoffs for VirtualPhenotype through meta analyses of clinical trial and cohort dataAntivir. Ther., 9
-
VA Johnson (2005)
Update of the drug resistance mutations in HIV-1: fall 2005Top. HIV Med., 13
-
H Vermeiren (2004)
Application of multiple linear regression modelling to the quantitative prediction of HIV-1 drug susceptibility phenotype from viral genotypeAntivir. Ther., 9
-
AS Foulkes, V De Gruttola (2003)
Characterizing classes of antiretroviral drugs by genotypeStat. Med., 22
-
K Wang, R Samudrala, JE Mittler (2004)
HIV-1 genotypic drug-resistance interpretation algorithms need to include hypersusceptibility-associated mutationsJ. Infect. Dis., 190
-
AG Marcelin (2005)
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patientsAntimicrob. Agents Chemother., 49
-
B Larder (2005)
Treatment history and adherence information significantly improves prediction of virological response by neural networksAntivir. Ther., 10
-
D Wang, B Larder (2003)
Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networksJ. Infect. Dis., 188
-
C Csajka, D Verotta (2006)
Pharmacokinetic–pharmacodynamic modelling: history and perspectivesJ. Pharmacokinet. Pharmacodyn., 33
-
P Flandre (2005)
Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar studyAntivir. Ther., 10
-
H Jiang (2003)
Assessing resistance costs of antiretroviral therapies via measures of future drug optionsJ. Infect. Dis., 188
-
JD Reeves, AJ Piefer (2005)
Emerging drug targets for antiretroviral therapyDrugs, 65
-
R Swanstrom (2004)
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsJ. Infect. Dis., 190
-
E Jenwitheesuk, K Wang, JE Mittler, R Samudrala (2004)
Improved accuracy of HIV-1 genotypic susceptibility interpretation using a consensus approachAIDS, 18
-
AG DiRienzo, V De Gruttola, B Larder, K Hertogs (2003)
Non-parametric methods to predict HIV drug susceptibility phenotype from genotypeStat. Med., 22
-
K Roomp (2006)
Data Integration in the Life Sciences -
MD Shenderovich, RM Kagan, PN Heseltine, K Ramnarayan (2003)
Structure-based phenotyping predicts HIV-1 protease inhibitor resistanceProtein Sci., 12
-
N Beerenwinkel (2003)
Methods for optimizing antiviral combination therapiesBioinformatics, 19
-
R Lathrop, M Pazzani (1999)
Combinatorial optimization in rapidly mutating drug-resistant virusesJ. Comb. Optim., 3
-
M Rabinowitz (2006)
Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimizationBioinformatics, 22
-
F Brun-Vezinet (2004)
Clinically validated genotype analysis: guiding principles and statistical concernsAntivir. Ther., 9
-
N Beerenwinkel (2001)
Geno2pheno: interpreting genotypic HIV drug resistance testsIEEE Intelligent Syst., 16
-
ET Maggio, M Shenderovich, R Kagan, D Goddette, K Ramnarayan (2002)
Structural pharmacogenomics, drug resistance and the design of anti-infective super-drugsDrug Discov. Today, 7
-
N Beerenwinkel (2003)
Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypesNucleic Acids Res., 31
-
S Draghici, RB Potter (2003)
Predicting HIV drug resistance with neural networksBioinformatics, 19
-
F Clavel, V Soriano, AR Zolopa (2004)
HIV infection -
E Jenwitheesuk, R Samudrala (2005)
Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approachAntivir. Ther., 10
-
D Wodarz, MA Nowak (2002)
Mathematical models of HIV pathogenesis and treatmentBioessays, 24
-
PM Sloot, AV Boukhanovsky, W Keulen, A Tirado-Ramos, CA Boucher (2005)
A Grid-based HIV expert systemJ. Clin. Monit. Comput., 19
-
MA Nowak, RM May (2000)
Virus Dynamics -
AS Foulkes, V De Gruttola (2003)
Characterizing the progression of viral mutations over timeJ. Am. Stat. Assoc., 98
- Publisher
- Springer Journals
- Copyright
- Copyright © 2006 by Nature Publishing Group
- Subject
- Life Sciences; Life Sciences, general; Microbiology; Medical Microbiology; Parasitology; Infectious Diseases; Virology
- ISSN
- 1740-1526
- eISSN
- 1740-1534
- DOI
- 10.1038/nrmicro1477
- Publisher site
- See Article on Publisher Site
Abstract
Highly active antiretroviral therapy (HAART) has had a major impact on the clinical management of HIV-1 infection. However, the emergence of resistant variants requires that follow-up drug regimens be optimized to maximum therapeutic effect. This article focuses on bioinformatics approaches that can be used to support anti-HIV therapy.
Journal
Nature Reviews Microbiology – Springer Journals
Published: Oct 1, 2006